Orthocell Ltd (OCC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.211x

Based on the latest financial reports, Orthocell Ltd (OCC) has a cash flow conversion efficiency ratio of -0.211x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.07 Million ≈ $-2.17 Million USD) by net assets (AU$14.57 Million ≈ $10.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See OCC defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Orthocell Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Orthocell Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Orthocell Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orthocell Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Texmaco Infrastructure & Holdings Limited NSE:TEXINFRA	0.139x
Sebo Manufacturing Engineering & Construction Corp KQ:011560	-0.008x
Orient Green Power Company Limited NSE:GREENPOWER	0.070x
Austral Resources Australia Ltd AU:AR1	-0.593x
Igarashi Motors India Limited NSE:IGARASHI	0.099x
Espey Mfg & Electronics Corp NYSE MKT:ESP	0.112x
BANK OF JIUJIANG H YC1 F:BJ8	N/A
Global Dividend Growth Split Corp Class A TO:GDV	0.008x

Annual Cash Flow Conversion Efficiency for Orthocell Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Orthocell Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Orthocell Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$14.57 Million ≈ $10.31 Million	AU$-8.68 Million ≈ $-6.14 Million	-0.596x	+58.47%
2024-06-30	AU$4.53 Million ≈ $3.21 Million	AU$-6.51 Million ≈ $-4.60 Million	-1.435x	-160.48%
2023-06-30	AU$6.15 Million ≈ $4.35 Million	AU$14.59 Million ≈ $10.33 Million	2.373x	+475.40%
2022-06-30	AU$9.90 Million ≈ $7.01 Million	AU$-6.26 Million ≈ $-4.43 Million	-0.632x	-130.23%
2021-06-30	AU$16.87 Million ≈ $11.94 Million	AU$-4.63 Million ≈ $-3.28 Million	-0.275x	-9.18%
2020-06-30	AU$20.90 Million ≈ $14.79 Million	AU$-5.26 Million ≈ $-3.72 Million	-0.251x	+35.49%
2019-06-30	AU$10.72 Million ≈ $7.59 Million	AU$-4.18 Million ≈ $-2.96 Million	-0.390x	+80.09%
2018-06-30	AU$2.37 Million ≈ $1.68 Million	AU$-4.64 Million ≈ $-3.29 Million	-1.958x	-159.49%
2017-06-30	AU$4.71 Million ≈ $3.33 Million	AU$-3.56 Million ≈ $-2.52 Million	-0.754x	-10.96%
2016-06-30	AU$4.88 Million ≈ $3.46 Million	AU$-3.32 Million ≈ $-2.35 Million	-0.680x	-7.70%
2015-06-30	AU$4.38 Million ≈ $3.10 Million	AU$-2.77 Million ≈ $-1.96 Million	-0.631x	+97.26%
2014-06-30	AU$76.19K ≈ $53.91K	AU$-1.75 Million ≈ $-1.24 Million	-23.009x	-8434.14%
2013-06-30	AU$1.08 Million ≈ $762.57K	AU$-290.57K ≈ $-205.60K	-0.270x	--

About Orthocell Ltd

AU:OCC Australia Biotechnology

Market Cap

$141.10 Million

AU$199.41 Million AUD

Market Cap Rank

#17942 Global

#540 in Australia

Share Price

AU$0.74

Change (1 day)

-4.55%

52-Week Range

AU$0.72 - AU$1.53

All Time High

AU$1.75